Leaflet AXALANZ 0.35mg tablets
Indicated for: Parkinson's disease
Route of administration: oral
Substance: pramipexole (antiparkinsonian agent)
ATC: N04BC05 (Nervous system | Dopaminergic agents | Dopamine agonists)
This medicine may affect your ability to drive or use machines.
This medicine may cause dizziness or vertigo.
May lower blood pressure and increase the risk of falls.
This medicine may cause drowsiness or reduced alertness.
Pramipexole is a dopamine receptor agonist used for the treatment of Parkinson's disease and restless legs syndrome. It works by stimulating dopamine receptors in the brain, alleviating motor and non-motor symptoms.
The medication is taken orally, as directed by a doctor, usually once to three times daily. It is important for patients to follow the treatment regimen and inform the doctor about any other medications being used.
Patients should be aware of potential side effects, such as drowsiness, dizziness, or nausea. It is important to inform the doctor of any unusual symptoms.
Common side effects include drowsiness, dizziness, and nausea. In rare cases, severe reactions such as hallucinations or compulsive behaviors may occur. Patients should be informed of these risks before use.
General data about AXALANZ 0.35mg
- Substance: pramipexole
- Date of last drug list: 01-07-2013
- Commercial code: W56180001
- Concentration: 0.35mg
- Pharmaceutical form: tablets
- Quantity: 30
- Product type: generic
- Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).
Pharmaceutical forms available for pramipexole
Concentrations available for pramipexole
- 0.088mg
- 0.18mg
- 0.26mg
- 0.35
- 0.35mg
- 0.52mg
- 0.54mg
- 0.70mg
- 0.7mg
- 1.05mg
- 1.1mg
- 1.57mg
- 2.10mg
- 2.1mg
- 2.62mg
- 3.15mg